Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - INTEREST INCOME & EXPENSE
Interest Income & Expense VRDN - Viridian Therapeutics, Inc.
1.85 M
LAST VALUE
2381.26%
2 YEAR CAGR
16.17%
5 YEAR CAGR
-0.61%
10 YEAR CAGR